Movement Disorder Sessions at the 12th EAN Congress
Geneva, Switzerland • June 27 - 30, 2026
The Following Sessions are offered in Partnership with the European Academy of Neurology (EAN).
Register now Full conference details
Use the hashtag #MDSatEAN to share your experience at the EAN Congress.
Day 1: Saturday, June 27, 2026
Symposium:
Tremor syndromes: From pathophysiology to emerging treatment approaches
10:30 - 12:30 CEST • Main Auditorium
Chairs: Roberto Erro, Antonella Macerollo
- Pathophysiology of tremor syndromes - Rich Helmich, The Netherlands
- Diagnostic criteria and clinical approach to tremor syndromes - Maria Stamelou, Greece
- Pharmacological and other, non-surgical, treatments of tremor syndromes - Roberto Erro, Italy
- Surgical options for tremor syndromes: Clinical indications, efficacy and safety - Antonella Macerollo, United Kingdom
|
Special Session: 15:30 – 17:00 CEST • Main Auditorium 
C. David Marsden Award Lecture: What to do if even David Marsden would not have a clue?
Bastiaan R. Bloem – Nijmegen, Netherlands
Dystonia Europe David Marsden Award Video Case Session Video Cases to be announced. |
Day 2: Sunday, June 28, 2026
Focused Workshop:
Current role and future perspectives of neuromodulation in the treatment of Parkinson's disease and dementia with Lewy bodies
8:30 - 10:00 CEST • Room Lisbon
Chair: Elena Moro
- Current role and future perspectives of deep brain stimulation in the treatment of PD – Elena Moro, France
- Focused ultrasound brain therapy is a new tool in the box – Günther Deuschl, Germany
- Potential of non-invasive brain stimulation (NIBS) for the treatment of PD and DLB – Irena Rektorova, Czech Republic
|
Scientific Theatre: 11:45 – 12:15 CEST • Scientific Theatre The International Parkinson and Movement Disorder Society (MDS) invites you to an engaging and informative session highlighting the latest updates in movement disorders and exciting upcoming MDS initiatives. Celebrate excellence as we recognize top-rated movement disorders abstracts selected for the EAN Congress, and gain valuable insights from leaders in the field. Following the presentation, connect directly with MDS leadership during an interactive Q&A session—your opportunity to ask questions and learn more about how MDS is shaping the future of movement disorder research and care.
|
Teaching course - Level 2
Spectrum of dementia and movement disorders
15:30 - 18:40 CEST • Room Lisbon
- Frontotemporal dementia – Amytrophic lateral sclerosis spectrum — Isabelle Le Ber, France
- Lewy Body Dementia and Parkinson’s Disease Dementia — Iracema Leroi, Ireland
- Clinical approach to complex phenotypes with cognitive impairment and movement disorders — Matej Skorvanek, Slovakia
- Imaging and fluid biomarkers in diagnosis of dementia — Federica Agosta - Italy
Hands-on course - Level 2
Botulinum toxin in neurological practice: A hands-on approach
17:30 - 19:00 CEST • Hands-on Course Room
- Ultrasound-guided demonstration (mannequin) — Kirsten Zeuner, Germany
- Botulinum Toxin Injection techniques with and without EMG guidance — Cenk Akbostanci, Turkiye
- Video demonstrations (Case-based learning) — Aleksandra Tomic, Serbia
Day 3: Monday, June 29, 2026
Focused Workshop:
Repurposing GLP-1 receptor agonists: A new frontiers for neuroprotection in neurological diseases
08:30 - 10:00 CEST • Room Lisbon
Chair: Federica Ferrari
- Beyond glycemic control: Uncovering the neuroprotective role of GLP-1 receptor agonists — Federica Ferrari, Italy
- GLP-1 receptor agonists in neurodegenerative diseases: What have we learned so far? – Dilan Athauda, United Kingdom
- GLP-1 receptor agonists for the treatment and prevention of stroke – Ellen Vercalsteren, Sweden
Symposium
Dementia with Lewy bodies: Current and future perspectives
11:00 - 12:30 CEST • Room Olso
Chairs: Irena Rektorova, Dag Aarsland
- Diagnosis of DLB within the framework of neuronal Lewy body diseases — Evelien Lemstra, The Netherlands
- Role of imaging in the assessment of neurodegeneration, longitudinal monitoring and target engagement — Daniel Ferreira, Sweden
- Neurophysiological biomarkers for disease stratification and longitudinal assessment — Laura Bonanni, Italy
- Treatment pathways, current and future perspectives — Dag Aarsland, United Kingdom
Interactive Session:
Pediatric and Early-on-set Movement Disorders in Daily Practice
Coordinated by MDS Young Members Group and EAN RRFS
11:00 - 12:30 CEST • Room Oslo
Chair: Giovanni Palermo
- Early-onset hypokinetic movement disorders – Giovanni Palermo, Italy
- Early-onset hyperkinetic movement disorders – Vanessa Carvalho, Portugal
- Movement disorders in children – H. Wieke Eggink, The Netherlands
Hands-on course - Level 2
Infusion therapies management in advanced Parkinson’s disease
11:00 - 12:30 CEST • HOC Room
- Continuous subcutaneous apomorphine infusion: Clinical indications and management — Tove Henriksen, Denmark
- Levodopa/carbidopa intestinal gel infusion: Clinical indications and management — Margherita Fabbri, France
- Levodopa/carbidopa Continuous subcutaneous infusion: Clinical indications and management — Bruno Bergmans, Belgium
Cased-based workshop
Tell me how you speak and I will tell you your neurological disease: A case-based journey across neurodegeneration
11:00 - 12:30 CEST • Case-based Workshop room
Chair: Antonio Suppa
- Patient with Bulbar Dysarthria - Susanne Petri – Germany
- Patient with hypophonia and monotonous speech: Parkinson, atypical parkinsonism, or depression? — Antonio Suppa, Italy
- Patient with cognitive-linguistic speech impairment: FTD, Alzheimer’s disease of psychogenic? – Jordi A. Matias-Guiu, Spain
Day 4: Tuesday, June 30, 2026
Hands On Course (BYO Laptop):
How to interpret genetic variants and genetic reports in neurological disorders
8:30 - 10:00 CEST • Geneva Room
Chair: Vincenzo Bonifati
- Variant types, frequency in population and disease datasets, and conservation assessment — Alessio Di Fonzo, Italy
- In silico pathogenicity prediction tools and the ACMG/AMP variant interpretation guidelines — Francesca Magrinelli, London
- The basics of a genetic report — Vincenzo Bonifati, Netherlands
Teaching course - Level 3
Synucleinopathies: Current and future treatment strategies
13:30 - 17:00 CEST • Copenhagen Room
Chair: Carlo Colosimo
- Current Concept of synucleinopathies in the era of biomarkers — Tiago Outeiro, Germany
- Management of motor symptoms in early and advanced Parkinson’s disease — Carlo Colosimo, Italy
- Dementia with Lewy Bodies: Identification and treatment — Milica Gregoric Kramberger, Slovenia
- Diagnose, cure and care for Multiple System Atrophy — Alessandra Fanciulli, Austria
MDS members are invited to use the hashtag #MDSatEAN to share their experience at the EAN Congress.
Visit the 12th EAN Congress Website for additional information or to register.